Astrana Health (NASDAQ:ASTH) Trading Up 7.9% – Time to Buy?

Shares of Astrana Health, Inc. (NASDAQ:ASTH) rose 7.9% on Friday . The stock traded as high as $40.67 and last traded at $40.7880. 282,394 shares changed hands during trading, a decline of 49% from the average session volume of 554,100 shares. The stock had previously closed at $37.79.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ASTH. Needham & Company LLC lifted their price target on Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. BTIG Research increased their price objective on Astrana Health from $50.00 to $65.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. TD Cowen raised their target price on shares of Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Wall Street Zen upgraded shares of Astrana Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Weiss Ratings raised shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $49.43.

Astrana Health Trading Up 7.5%

The company has a quick ratio of 1.35, a current ratio of 1.23 and a debt-to-equity ratio of 1.05. The stock’s fifty day moving average price is $41.29 and its two-hundred day moving average price is $32.77. The company has a market capitalization of $2.26 billion, a PE ratio of 49.63 and a beta of 0.87.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Strs Ohio purchased a new stake in Astrana Health in the 4th quarter worth approximately $40,000. Tower Research Capital LLC TRC increased its stake in shares of Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after buying an additional 3,517 shares during the period. State of Wyoming bought a new position in shares of Astrana Health during the second quarter valued at approximately $132,000. Los Angeles Capital Management LLC bought a new position in shares of Astrana Health during the fourth quarter valued at approximately $228,000. Finally, WINTON GROUP Ltd bought a new position in shares of Astrana Health during the second quarter valued at approximately $233,000. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.